Eli Lilly to acquire three vaccine manufacturers for up to $3.8 billion
By
Rowan Walrath
Fresh out the oven, still warm. Top of the tray.
Summary
Eli Lilly is spending up to $3.8 billion to acquire three vaccine manufacturing companies, significantly expanding its presence in the immunology and vaccine space. The move represents a major strategic push by the pharmaceutical giant to strengthen its position in vaccine development and production capabilities.
Key quotes
· 1 pulledEli Lilly and Company is spending up to $3.8 billion to buy three vaccine makers, supercharging its push into the immunology space.
You might also wanna read
UnitedHealthcare Denied 33% of Claims in 2023 While Posting Record Profits, Analysis Shows
UnitedHealthcare denied 33% of all claims in 2023, while its parent company UnitedHealth Group reported $22.4 billion in net earnings and re
Tech Companies Stock Offices with Nicotine Products to Boost Employee Productivity
Tech companies like Palantir and Hello Patient are stocking office vending machines with nicotine products (pouches from startups Lucy and S
Tech Companies Stock Offices with Nicotine Products to Boost Employee Productivity
Tech companies like Palantir and Hello Patient are stocking office vending machines with nicotine products (pouches from startups Lucy and S

How one mother's search for clean prenatal vitamins led to a $250M supplement brand
In 2015, Katerina Markov Schneider, newly pregnant and dissatisfied with the heavy metals and artificial ingredients in available prenatal v
Karex: The world's largest condom maker faces pressure in Malaysia
Malaysia, a historic rubber producer with about 150 years of experience, is home to Karex, the world's largest condom manufacturer. The arti
The Collapse of Providence Health Plan: Employees Question Leadership's Account
An investigation into the collapse of Providence Health Plan, one of Oregon's largest health insurers. CEO Don Antonucci declined to be inte
